PlainPill

MK-2866 vs MK-677 for performance

Short answer: For performance, users rate them about the same: 87% report improvement with MK-2866 (252 reports) and 90% with MK-677 (87 reports).

MK-2866 has 0 meta-analyses and 0 randomized trials on PubMed; MK-677 has 0 and 15.

Based on 789 reports about MK-2866 and 978 about MK-677. Not medical advice.

MK-2866
SARM
MK-677
Substance
Users say it helped37%helped489 reports · high confidence39%helped479 reports · high confidence
Verdict
Mixed
Mixed
ResearchDResearch: NoneBResearch: Moderate
Meta-analyses / RCTs0 / 00 / 15
Mainly used for
Performance
% reporting improvement
87% (252)90% (87)
Appetite
% reporting improvement
56% (9)66% (228)
Sleep
% reporting improvement
16% (25)79% (170)
Recovery
% reporting improvement
96% (78)99% (106)
Weight loss
% reporting improvement
88% (100)53% (55)
Common side effectssuppression, fatigue, insomnia, headachewater retention, fatigue, stomach issues, hunger
Typical dose reportedNot listed12.5 mg / before dinner
MK-2866
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full MK-2866 profile →
MK-677
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Full MK-677 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate